Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
Pediatric Endocrine Society, 2025, (PES)
Congresses
{{structuredDataObject}}
Maryland
,
USA
15 - 18 May 2025
Pediatric Endocrine Society, 2025, (PES)
Presentation schedule and materials
Friday, 16 May 2025
12:30
- 14:30
EDT
POSTER
Preference of somapacitan pen-injector or lonapegsomatropin autoinjector, reported by participants with growth-related disorders and caregivers
Johan Medina
1
; Gitte Ter-Borch
2
; Nicky Kelepouris
3
; Sophie Hamilton
3
; Maya Gonczi
4
; Jørgen Vinsløv Hansen
5
; Shahid Akhtar
1
MATERIALS AVAILABLE
Poster
Share
Copy link
{{pageUrl}}
Keywords
Rare Endocrine Disorder
PES